The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
Manjaro which is the just the Branded name for terzapatide comes in uh same same thing right it's a pre-loaded pen that you inject so you don't have to draw it up or anything like that it comes in increments I believe it's 2.55 7.5 10 12.5 all the way up to 15 milligrams and um it was approved relatively recently for type 2 diabetes
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.